SEC Form 4 · accession 0001437749-16-027046
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Tobin
Director
Period of report
Mar 4, 2016
Accepted (ET)
Mar 8, 2016 · 12:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 4, 2016 | M | 5,000 | $10.25 | A | 35,868 | D | |
| Common StockF1 | Mar 4, 2016 | F | 3,034 | $10.25 | D | 32,834 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NonQualified Stock Option (Right to Buy) | $10.25 | Mar 4, 2016 | X | 5,000 | A | May 21, 2009 | May 21, 2016 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1Mr. Tobin surrendered to the Issuer the right to receive an aggregate of 3,034 shares of Common Stock. Mr. Tobin did not sell any shares of Common Stock in connection with the foregoing exercise.